JOHN BIVONA: Open Payments
NPI 1740338904 · JASPER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,950 in 160 payments from 29 companies in 2025. Trend: 2023 $2,431 · 2024 $2,562 · 2025 $2,950
Food & beverage: $2,950
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $383 |
| Vanda Pharmaceuticals Inc. | 11 | $340 |
| AstraZeneca Pharmaceuticals LP | 10 | $221 |
| Otsuka America Pharmaceutical, Inc. | 14 | $181 |
| Exact Sciences Corporation | 9 | $175 |
| Ardelyx, Inc. | 8 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $161 |
| PFIZER INC. | 8 | $137 |
| TOLMAR, INC. | 10 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $128 |
Products named: FANAPT, VRAYLAR, REXULTI, IBSRELA, CAPLYTA, JATENZO, TRINTELLIX, The Cologuard Plus Collection Kit.
Industry payments across AL — which companies pay providers there.
